Skip to content
StockMarketAgent
Direct answer
CRWD trades against a final fair-value range of $91.54-$123.84, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $91.5, high $124, with mid-point at $108.
Stock analysis

CRWD CrowdStrike Holdings Inc. fair value $108–$124

CRWD
By StockMarketAgent.AI team· supervised by
已分析: 2026-05-08下次更新: 2026-08-08Methodology v2.4Archetype: Pre-profitNASDAQ · Information Technology
View archive
股价
$468.07
▼ -360.38 (-76.99%)
公允价值
$108
$108–$124
评级
卖出
confidence 74/100
上行空间
-77.0%
upside to fair value
安全边际
$91.54
buy below · 15%
市值
$119.1B
P/E fwd 75.9
英文原文ZH
翻译期间显示英文原文
此报告尚未翻译。翻译队列赶上后请在几分钟内刷新。

§1 执行摘要

  • Composite fair value $108 with high case $124.
  • Implied downside of 77.0% to fair value.
  • Moat 6.5/10 · confidence 74/100 · Pre-profit.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$108
Margin of safety
-334.6%
Confidence
74/100
Moat
6.5/10

Educational analysis only — not financial advice. Always do your own due diligence.

$468.07Price
FV $107.69
High $123.84

CRWD trades against a final fair-value range of $91.54-$123.84, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • High switching costs associated with
    High switching costs associated with deeply embedded endpoint agents.
  • Network effects from vast threat
    Network effects from vast threat intelligence data lake.
  • Cycle upside
    Vendor consolidation favors integrated platforms like Falcon.

§2 看空情景

At current multiples, the stock offers zero margin of safety. A failure to execute flawlessly on top-line growth or margin expansion will trigger a severe multiple contraction.

该论点可能失败的方式

Margin Compression

· High

Fierce competition from Microsoft and PANW forces pricing compression, capping terminal margins below 20%.

FV impact
-30%

SBC Dilution

· Medium

Failure to rein in excessive stock-based compensation (22.7% of revenue) structurally impairs per-share intrinsic value.

FV impact
-20%

Growth Deceleration

· Low

Market saturation in endpoint security causes revenue growth to decelerate sharply below the 20% required by current multiples.

FV impact
-50%
需关注的早期预警信号
指标当前触发阈值
Net new ARR growth decelerates for two consecutive quarters.MonitorDeterioration versus the report thesis
Gross retention dips below 97%.MonitorDeterioration versus the report thesis
SBC remains above 20% of revenue without a clear path to the 7.8% industry median.MonitorDeterioration versus the report thesis
Operating margins fail to scale towards the 30% terminal target.MonitorDeterioration versus the report thesis
Increased discounting observed in enterprise renewals.MonitorDeterioration versus the report thesis

§3 财务历史

损益表 — 最近六期
项目T−0T−1T−2T−3T−4CAGR
期间2022-01-312023-01-312024-01-312025-01-312026-01-31Trend
营业收入$1.45B$2.24B$3.06B$3.95B$4.81B+34.9%
毛利$1.07B$1.64B$2.30B$2.96B$3.59B+35.4%
营业利润$-142.5M$-190.1M$-2.0M$-120.4M$-293.3M
净利润$-234.8M$-183.2M$89.3M$-19.3M$-162.5M
每股收益(摊薄)$-1.03$-0.79$0.37$-0.08
EBITDA$-66.0M$-40.8M$293.8M$294.8M$182.5M
研发$371.3M$608.4M$768.5M$1.08B$1.38B+39.0%
销售管理费用$839.6M$1.22B$1.53B$2.01B$2.50B+31.4%

质量评分

Piotroski F 评分
4 / 9
0–9 质量综合
Altman Z 评分
11.4
破产风险 (>3 安全)
Beneish M 评分
-2.95
盈利操纵风险
OCF / 净利润
-9.92
>1 表示盈利质量高
会计质量门槛
Fail
经行业调整门槛
ROIC
34.9%
投入资本回报率
第 3 节

Numbers analysis

现金流

Cash-flow quality is reflected in the OCF / net income, accounting-quality, and ROIC rows above.

资本配置

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

个人订阅用户 — §4 及之后还有 11 个章节

阅读完整分析 — 还有 11 个章节。

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

涵盖每个股票的完整报告
24 个月的评级存档
关注列表简报 + 评级变更提醒
以任意语言导出 PDF + DOCX
开始免费试用
可随时取消。
FAQ

CRWD — frequently asked questions

  1. Based on our latest independent analysis, CRWD looks meaningfully overvalued. The current price is $468 versus a composite fair-value midpoint of $108 (range $91.5–$124), which implies roughly 77.0% downside to the midpoint.